Studies have identified BRCA1 and BRCA2 variants among early-onset CRC (1.3%) [33], high-risk CRC (0.2%) [34], and unselected CRC patients (1.0%) [35] at a higher frequency. The gene discussed is BRCA2; the disease is colorectal carcinoma.